Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kambiz Rahbar

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Medical & Biological Engineering & Computing|April 6, 2025
Enhancing breast cancer diagnosis: transfer learning on DenseNet with neural hashing for histopathology fine-grained image classificationFatemeh Taheri, Kambiz Rahbar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
The Imperative for Comparative Studies in Nuclear Medicine: Elevating <sup>177</sup>Lu-PSMA-617 in the Treatment Paradigm for mCRPCKambiz Rahbar, Martin Boegemann
Health Information Science and Systems|September 26, 2025
Introduction of hierarchical deep features based on the VGG-16 model for enhancing diabetic retinopathy classificationFatemeh Taheri, Kambiz Rahbar
Clinical Nuclear Medicine|September 21, 2020
Re: Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With HyperthyroidismKambiz Rahbar, Hojjat Ahmadzadehfar
BMC Cancer|July 10, 2025
Utility of the prostest to predict and monitor response to chemotherapy in metastatic Castration-Resistant prostate cancer: A prospective pilot studyKambiz Rahbar, Katrin Schlack, Martin Bögemann
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2017
<sup>177</sup>Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?Kambiz Rahbar, Hojjat Ahmadzadehfar, Martin Boegemann
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2016
<sup>177</sup>Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of responseKambiz Rahbar, Martin Bögemann, Hojjat Ahmadzadehfar
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|December 11, 2013
Phase wavefront aberration modeling using Zernike and pseudo-Zernike polynomialsKambiz Rahbar, Karim Faez, Ebrahim Attaran Kakhki
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of TheranosticsKambiz Rahbar, Lisa Bodei, Michael J Morris
Applied Optics|June 15, 2012
Estimation of phase wave-front aberration distribution function using wavelet transform profilometryKambiz Rahbar, Karim Faez, Ebrahim Attaran-Kakhki
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Medical & Biological Engineering & Computing|April 6, 2025
Enhancing breast cancer diagnosis: transfer learning on DenseNet with neural hashing for histopathology fine-grained image classificationFatemeh Taheri, Kambiz Rahbar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
The Imperative for Comparative Studies in Nuclear Medicine: Elevating <sup>177</sup>Lu-PSMA-617 in the Treatment Paradigm for mCRPCKambiz Rahbar, Martin Boegemann
Health Information Science and Systems|September 26, 2025
Introduction of hierarchical deep features based on the VGG-16 model for enhancing diabetic retinopathy classificationFatemeh Taheri, Kambiz Rahbar
Clinical Nuclear Medicine|September 21, 2020
Re: Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With HyperthyroidismKambiz Rahbar, Hojjat Ahmadzadehfar
BMC Cancer|July 10, 2025
Utility of the prostest to predict and monitor response to chemotherapy in metastatic Castration-Resistant prostate cancer: A prospective pilot studyKambiz Rahbar, Katrin Schlack, Martin Bögemann
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2017
<sup>177</sup>Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?Kambiz Rahbar, Hojjat Ahmadzadehfar, Martin Boegemann
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2016
<sup>177</sup>Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of responseKambiz Rahbar, Martin Bögemann, Hojjat Ahmadzadehfar
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|December 11, 2013
Phase wavefront aberration modeling using Zernike and pseudo-Zernike polynomialsKambiz Rahbar, Karim Faez, Ebrahim Attaran Kakhki
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of TheranosticsKambiz Rahbar, Lisa Bodei, Michael J Morris
Applied Optics|June 15, 2012
Estimation of phase wave-front aberration distribution function using wavelet transform profilometryKambiz Rahbar, Karim Faez, Ebrahim Attaran-Kakhki
Pageof 16